What is the official website of Jubilant Radiopharma ?

The official website of Jubilant Radiopharma is http://www.jubilantradiopharma.com.

What is Jubilant Radiopharma's cybersecurity risk score?

Jubilant Radiopharma has an AI-generated cybersecurity risk score of 756 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Jubilant Radiopharma experienced?

According to Rankiteo, Jubilant Radiopharma currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Jubilant Radiopharma been affected by any supply chain cyber incidents ?

According to Rankiteo, Jubilant Radiopharma has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Jubilant Radiopharma have SOC 2 Type 1 certification ?

According to Rankiteo, Jubilant Radiopharma is not certified under SOC 2 Type 1.

Does Jubilant Radiopharma have SOC 2 Type 2 certification ?

According to Rankiteo, Jubilant Radiopharma does not hold a SOC 2 Type 2 certification.

Does Jubilant Radiopharma comply with GDPR ?

According to Rankiteo, Jubilant Radiopharma is not listed as GDPR compliant.

Does Jubilant Radiopharma have PCI DSS certification ?

According to Rankiteo, Jubilant Radiopharma does not currently maintain PCI DSS compliance.

Does Jubilant Radiopharma comply with HIPAA ?

According to Rankiteo, Jubilant Radiopharma is not compliant with HIPAA regulations.

Does Jubilant Radiopharma have ISO 27001 certification ?

According to Rankiteo,Jubilant Radiopharma is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Jubilant Radiopharma operate in ?

Jubilant Radiopharma operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Jubilant Radiopharma have ?

Jubilant Radiopharma employs approximately 585 people worldwide.

Does Jubilant Radiopharma own any subsidiaries ?

Jubilant Radiopharma presently has no subsidiaries across any sectors.

How many LinkedIn followers does Jubilant Radiopharma have ?

Jubilant Radiopharma's official LinkedIn profile has approximately 23,155 followers.

Does Jubilant Radiopharma have a Crunchbase profile ?

No, Jubilant Radiopharma does not have a profile on Crunchbase.

Does Jubilant Radiopharma have a LinkedIn profile ?

Yes, Jubilant Radiopharma maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/jubilant-radiopharma.

How many cybersecurity incidents has Jubilant Radiopharma experienced ?

As of August 30, 2026, Rankiteo reports that Jubilant Radiopharma has not experienced any cybersecurity incidents.

How many peer or competitor companies does Jubilant Radiopharma have ?

Jubilant Radiopharma has an estimated 5,746 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Jubilant Radiopharma

Boost Score +25 with badge (5 left)

756

/1000

Fair

781

/1000

Fair

Jubilant Radiopharma Vendor Cyber Rating & Cyber Score

jubilantradiopharma.com

Add Your Compliance Badge

Jubilant Radiopharma is an industry leading pharmaceutical company specializing in nuclear medicine focused on developing, manufacturing, commercializing and distributing high quality and sustainable diagnostic and therapeutic agents for the sole purpose of Improving Lives Through Nuclear Medicine on a global scale.

Jubilant Radiopharma A.I CyberSecurity Scoring

Scoring History

Jubilant Radiopharma

Jubilant Radiopharma CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

Jubilant Radiopharma Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Jubilant Radiopharma

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Jubilant Radiopharma in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Jubilant Radiopharma in 2026.

Incident Types Jubilant Radiopharma vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Jubilant Radiopharma in 2026.

Incident History - Jubilant Radiopharma (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Jubilant Radiopharma Subsidiaries

Jubilant Radiopharma

Pharmaceutical Manufacturing

Website: http://www.jubilantradiopharma.com

Company Size: 585

Jubilant Pharmova LimitedPharmaceutical Manufacturing

Jubilant Life Sciences Alumni NetworkPharmaceutical Manufacturing

Jubilant Biosys LimitedResearch

Jubilant Chemsys -> Jubilant Biosys LimitedPharmaceutical Manufacturing

Jubilant Generics LimitedPharmaceutical Manufacturing

Jubilant Pharma LimitedPharmaceutical Manufacturing

Jubilant HollisterStier CMOPharmaceutical Manufacturing

Sterile Ophthalmics & OticsPackaging & Containers

Non-Sterile Topicals and LiquidsPharmaceutical Manufacturing

High Speed Ampoule FillingPharmaceutical Manufacturing

Jubilant Therapeutics IncBiotechnology

Jubilant Cadista PharmaceuticalsPharmaceutical Manufacturing

HollisterStier AllergyPharmaceutical Manufacturing

Loading…

Jubilant Radiopharma Similar Companies

Lonza

lonza.com

Lonza is a pioneer and world leader in the CDMO industry, setting the pace with cutting-edge science, smart technology, and lean manufacturing. United by a common purpose, we turn our customers’ breakthrough innovations into viable therapies and manufacture the medicines of tomorrow. Founded in Switzerland in 1897, our company is the first and original CDMO, and today we are more dynamic, agile and forward-focused than ever before. As one of the largest Western CDMOs, we bring together a global team of around 18,500 colleagues across five continents to deliver comprehensive, integrated solutions for our customers' complex needs. For our customers and their patients, we bring quality, safety and reliability to bring life-enhancing and life-saving treatments to market at speed and at scale. For our colleagues, we strive to create a sense of belonging and inclusion where every person can thrive and bring their best.

Hikma Pharmaceuticals

cb hikma.com

For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 800* high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists need to treat their patients across North America, MENA and Europe. We have 29 manufacturing plants, 3 R&D hubs and c9,500 employees worldwide. *As of December 2025 Subscribe to our channel on YouTube https://youtube.com/@hikmapharmaceuticals5668 For all product information and enquiries, please contact us at [email protected]

Lupin

lupin.com

Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 23,000 professionals. Lupin is committed to improving patient health outcomes through its subsidiaries – Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions.

Ipca Laboratories Limited

ipca.com

A consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense of responsibiliti and a need for utmost integriti in everything you do. As you serve millions of lives, high qualiti standards become a pre-requisite, and safeti of your people and consumers always comes first. All this, while ensuring that each life you touch is treated with respect and digniti. For more than 60 years, Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents. We are a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments. Today, we are one of the world’s largest manufacturers and suppliers of over a dozen APIs. These are produced from scratch at fully-automated manufacturing facilities, approved by the world’s most discerning drug regulatory authorities like UK-MHRA, EDQM-Europe, and WHO-Geneva, among others. - One of the largest suppliers of these APIs worldwide with manufacturing leadership in over 12 APIs globally - 15 APIs & 11 Formulations manufacturing facility across the globe Leader in DMARDs (Disease Modifying Anti-Rheumatic Drugs) treatment for Rheumatoid Arthritis - Leading brands in Pain, Rheumatology, Antimalarials and Hair care therapy - 4 formulations rank amongst the top 300 brands of IPM as per IQVIA

SUN PHARMA

sunpharma.com

Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread across 5 continents, R&D centres across the globe, and a multicultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising around 3,000 scientists and R&D investments of over 6-8% of annual revenues. At Sun, our people are our greatest asset. Ours has never been a story of individual brilliance but of cultivating a culture of realising collective potential. In our journey, everyone is enabled to take charge in an environment that offers limitless growth opportunities. We are with you every step of the way, so you can shine for years to come. With the launch of our Employee Value Proposition (EVP), we define our promise to ‘Create Your Own Sunshine'—driven by the three pillars of Better Every Day, Take Charge, and Thrive Together. These pillars drive progress at Sun so that people can achieve what they would have thought impossible. Learn more about our EVP here: https://sunpharma.com/careers/

Zydus Group

zyduslife.com

The Zydus Group with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global life-sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs over 27000 people worldwide and is driven by its mission to unlock new possibilities in life-sciences through quality healthcare solutions that impact lives. The group aspires to transform lives through pathbreaking discoveries.

Johnson & Johnson Innovative Medicine

cb jnj.com

At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we confidently address the most complex diseases of our time and develop the potential medicines of tomorrow. We are continuously working to develop treatments, aspiring to find cures, pioneering the path from lab to life, and championing patients every step of the way. https://bit.ly/3reuMvK

Glenmark Pharmaceuticals

glenmarkpharma.com

Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our journey of innovation over the past four and a half decades, we have evolved from a generics company to a global organization offering specialty and branded products. Glenmark’s core values of Achievement, Respect, and Knowledge impart a sense of organizational unity that drives our growth. We have established a robust global branded generics, specialty, and OTC business; with a significant presence in the therapy areas of dermatology, respiratory, and oncology. Our ten state-of-the-art manufacturing facilities spread across four continents with operations in over 80 countries help us impact millions of patients across the globe. We recently consolidated our innovation efforts in small molecules and biologics research with the formation of ‘Ichnos Glenmark Innovation’ (IGI). This alliance is aimed at leveraging the capabilities of Glenmark and its subsidiary, Ichnos Sciences, to accelerate innovation in cancer treatment. To know more about IGI, check out: https://iginnovate.com/ Sustainability is an integral aspect of all our operations and we are focused on achieving our Environment, Social and Governance (ESG) goals. Our responsibility also extends to our communities, and over the years, our CSR efforts have touched the lives of over 3 million people.

MSD

msd.com

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.com and connect with us on Facebook, Instagram, Twitter, and YouTube.

Loading…

NEWS

Jubilant Radiopharma CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

January 31, 2025 08:00 AM

Jubilant Pharmova Q3 result: Profit rises 51% to Rs 101 cr on strong demand

Revenue rose 9 per cent to Rs 1814 crore, lifted by the radiopharma segment's nearly 12 per cent growth this quarter.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-82424

SUMMARY

A weakness has been identified in PHPGurukul Student Information System 1.0. Affected by this vulnerability is an unknown functionality of the file /student_edit1.php. Executing a manipulation of the argument ID can lead to sql injection. The attack can be launched remotely. The exploit has been made available to the public and could be used for attacks.

Published

Date2026-08-29

Updated

Date2026-08-29

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

CVE-2026-82423

SUMMARY

A vulnerability has been found in macrozheng mall up to 1.0.3. The affected element is an unknown function of the file /order/paySuccess of the component Payment Status Endpoint. The manipulation of the argument orderId leads to enforcement of behavioral workflow. The attack is possible to be carried out remotely. The vendor deleted the GitHub issue for this vulnerability without any explanation.

Published

Date2026-08-29

Updated

Date2026-08-29

RISK INFORMATION (Score: 5.4)

cvss2

Base Score: 5.5

Complexity: LOW

AV:N/AC:L/Au:S/C:N/I:P/A:P

cvss3

Base Score: 5.4

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

2.5

Exploitability

2.8

REFERENCES

CVE-2026-82422

SUMMARY

A security flaw has been discovered in itsourcecode Sales and Inventory System 1.0. Impacted is an unknown function of the file /pages/emp_del.php. The manipulation of the argument ID results in sql injection. The attack may be launched remotely. The exploit has been released to the public and may be used for attacks.

Published

Date2026-08-29

Updated

Date2026-08-29

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

CVE-2026-82421

SUMMARY

A vulnerability was identified in itsourcecode Sales and Inventory System 1.0. This issue affects some unknown processing of the file /pages/emp_edit.php. The manipulation of the argument ID leads to sql injection. The attack may be initiated remotely. The exploit is publicly available and might be used.

Published

Date2026-08-29

Updated

Date2026-08-29

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

CVE-2026-15369

SUMMARY

The Custom User Registration Fields for WooCommerce plugin for WordPress is vulnerable to Privilege Escalation in versions up to, and including, 2.2.3. This is due to the plugin accepting an attacker-controlled afreg_select_user_role value from the unauthenticated WooCommerce Store API /wc/store/v1/checkout request in the af_reg_checkout_data_to_order_meta_data_block() function, persisting it in order meta, and then passing it directly to WP_User::add_role() in the af_reg_custom_order_processing_function() function (hooked to woocommerce_thankyou) without validating against the plugin's admin-configured allowed role list. This makes it possible for unauthenticated attackers to elevate their privileges to Administrator by creating an account during checkout with a modified JSON body specifying administrator (or any other role slug) as the desired role. Note: The exploit requires the "User Role Selection" setting to be enabled.

Published

Date2026-08-29

Updated

Date2026-08-29

RISK INFORMATION (Score: 9.8)

cvss3

Base Score: 9.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

3.9

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…